PubMed:21421994 / 1328-1499 JSONTXT

Annnotations TAB JSON ListView MergeView

    Glycan-Motif

    {"project":"Glycan-Motif","denotations":[{"id":"T5","span":{"begin":5,"end":12},"obj":"https://glytoucan.org/Structures/Glycans/G70323CJ"}],"text":"High-mannose content of therapeutic Mabs should be considered an important product quality attribute which may affect pharmacokinetic properties of therapeutic antibodies."}

    GlyCosmos6-Glycan-Motif-Image

    {"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T5","span":{"begin":5,"end":12},"obj":"Glycan_Motif"}],"attributes":[{"id":"A5","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G70323CJ"}],"text":"High-mannose content of therapeutic Mabs should be considered an important product quality attribute which may affect pharmacokinetic properties of therapeutic antibodies."}

    GlyCosmos6-Glycan-Motif-Structure

    {"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T5","span":{"begin":5,"end":12},"obj":"https://glytoucan.org/Structures/Glycans/G70323CJ"}],"text":"High-mannose content of therapeutic Mabs should be considered an important product quality attribute which may affect pharmacokinetic properties of therapeutic antibodies."}

    GlycoBiology-FMA

    {"project":"GlycoBiology-FMA","denotations":[{"id":"_T31","span":{"begin":5,"end":12},"obj":"FMAID:82801"},{"id":"_T32","span":{"begin":5,"end":12},"obj":"FMAID:196796"},{"id":"_T33","span":{"begin":160,"end":170},"obj":"FMAID:167180"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"High-mannose content of therapeutic Mabs should be considered an important product quality attribute which may affect pharmacokinetic properties of therapeutic antibodies."}

    GO-MF

    {"project":"GO-MF","denotations":[{"id":"T3","span":{"begin":160,"end":170},"obj":"http://purl.obolibrary.org/obo/GO_0003823"}],"text":"High-mannose content of therapeutic Mabs should be considered an important product quality attribute which may affect pharmacokinetic properties of therapeutic antibodies."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T9","span":{"begin":0,"end":171},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":171},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":171},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"High-mannose content of therapeutic Mabs should be considered an important product quality attribute which may affect pharmacokinetic properties of therapeutic antibodies."}